Efficacy and safety of initial combined therapy with metformin plus a dipeptidyl peptidase-4 inhibitor versus metformin monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of phase 3 randomised controlled trials

被引：0
|
作者：
Tangney, N. [1 ]
De Buitleir, C. [1 ,2 ,3 ]
O'Brien, T. [1 ,2 ]
Liew, A. [1 ,2 ,3 ]
机构：
[1] Galway Univ Hosp, Galway, Ireland
[2] NUIG, Discipline Med, Galway, Ireland
[3] Portiuncula Univ Hosp, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2019年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P132
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of combined therapy with metformin and a sodium-glucose-co-transporter-2 inhibitor vs metformin monotherapy in treatment-naive Type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Capin, I.
    Tobin-Schnittger, P.
    Ong, G.
    Shaw, J.
    Liew, A.
    DIABETIC MEDICINE, 2017, 34 : 161 - 161
  • [22] A comparison of intensive insulin therapy and dipeptidyl peptidase-4 inhibitor plus metformin combination in newly diagnosed type 2 diabetes mellitus
    Diri, Halit
    Bolayir, Basak
    Soylu, Hikmet
    Cetin, Sedat
    Simsek, Mehmet
    MINERVA ENDOCRINOLOGY, 2024, 49 (02): : 228 - 230
  • [23] Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Doni, Katharina
    Buehn, Stefanie
    Weise, Alina
    Mann, Nina-Kristin
    Hess, Simone
    Soennichsen, Andreas
    Pieper, Dawid
    Thuermann, Petra
    Mathes, Tim
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2022, 13
  • [24] Efficacy and safety of vildagliptin combined with metformin in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
    Xu, Ting
    Zhan, Mei
    Jiang, Xuehua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 9495 - +
  • [25] Efficacy and safety of initial combination of DPP-IV inhibitors and metformin versus metformin monotherapy in type 2 diabetes: a systematic review of randomized controlled trials
    Gao, W.
    Dong, J.
    Liu, J.
    Li, Y.
    Liu, F.
    Yang, L.
    Zhou, X.
    Liao, L.
    DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 179 - 185
  • [26] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
    Park, Haesuk
    Park, Chanhyun
    Kim, Yoona
    Rascati, Karen L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1453 - 1469
  • [27] Effect of dipeptidyl peptidase-4 inhibitors on the progression of atherosclerosis in patients with type 2 diabetes mellitus: A meta-analysis of randomised controlled trials
    Shi, Hongshuo
    Peng, Min
    Liu, Yufan
    Kan, Zunqi
    Li, Wenwen
    Yang, Tiantian
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [28] Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
    Hongmei Zhu
    Shuang Zhu
    Xiuqian Zhang
    Yang Guo
    Yunzhen Shi
    Zhimin Chen
    Siu-wai Leung
    Diabetology & Metabolic Syndrome, 5
  • [29] Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
    Zhu, Hongmei
    Zhu, Shuang
    Zhang, Xiuqian
    Guo, Yang
    Shi, Yunzhen
    Chen, Zhimin
    Leung, Siu-wai
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [30] Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-Analysis
    Cai, Xiaoling
    Gao, Xueying
    Yang, Wenjia
    Ji, Linong
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) : 704 - 714
12345